These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32875686)

  • 1. Attention-deficit/hyperactivity disorder medication and risk of suicide attempt: A meta-analysis of observational studies.
    Liu WJ; Mao HJ; Hu LL; Song MF; Jiang HY; Zhang L
    Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1364-1372. PubMed ID: 32875686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Suicide Attempts.
    Chang Z; Quinn PD; O'Reilly L; Sjölander A; Hur K; Gibbons R; Larsson H; D'Onofrio BM
    Biol Psychiatry; 2020 Sep; 88(6):452-458. PubMed ID: 31987492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicidal ideation and attempts in the United States of America among stimulant-treated, non-stimulant-treated, and untreated patients with a diagnosis of attention-deficit/hyperactivity disorder.
    Siffel C; DerSarkissian M; Kponee-Shovein K; Spalding W; Gu YM; Cheng M; Duh MS
    J Affect Disord; 2020 Apr; 266():109-119. PubMed ID: 32063553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suicide risk reduction in youths with attention-deficit/hyperactivity disorder prescribed methylphenidate: A Taiwan nationwide population-based cohort study.
    Liang SH; Yang YH; Kuo TY; Liao YT; Lin TC; Lee Y; McIntyre RS; Kelsen BA; Wang TN; Chen VC
    Res Dev Disabil; 2018 Jan; 72():96-105. PubMed ID: 29121517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of suicide attempts in adolescents and young adults with attention-deficit hyperactivity disorder: a nationwide longitudinal study.
    Huang KL; Wei HT; Hsu JW; Bai YM; Su TP; Li CT; Lin WC; Tsai SJ; Chang WH; Chen TJ; Chen MH
    Br J Psychiatry; 2018 Apr; 212(4):234-238. PubMed ID: 29501070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis.
    Zhang L; Yao H; Li L; Du Rietz E; Andell P; Garcia-Argibay M; D'Onofrio BM; Cortese S; Larsson H; Chang Z
    JAMA Netw Open; 2022 Nov; 5(11):e2243597. PubMed ID: 36416824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicide risk in attention-deficit/hyperactivity disorder.
    Giupponi G; Giordano G; Maniscalco I; Erbuto D; Berardelli I; Conca A; Lester D; Girardi P; Pompili M
    Psychiatr Danub; 2018 Mar; 30(1):2-10. PubMed ID: 29546852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common etiological factors of attention-deficit/hyperactivity disorder and suicidal behavior: a population-based study in Sweden.
    Ljung T; Chen Q; Lichtenstein P; Larsson H
    JAMA Psychiatry; 2014 Aug; 71(8):958-64. PubMed ID: 24964928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADHD, stimulant medication use, and the risk of fracture: a systematic review and meta-analysis.
    Zhang SW; Shen D; Yan YT
    Arch Osteoporos; 2021 Jun; 16(1):81. PubMed ID: 34076749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Pharmacological Treatment for Attention-Deficit/Hyperactivity Disorder on Physical Injuries: A Systematic Review and Meta-Analysis of Observational Studies.
    Man KKC; Ip P; Chan EW; Law SL; Leung MTY; Ma EXY; Quek WT; Wong ICK
    CNS Drugs; 2017 Dec; 31(12):1043-1055. PubMed ID: 29255995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
    Verbeeck W; Bekkering GE; Van den Noortgate W; Kramers C
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009504. PubMed ID: 28965364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal and neonatal outcomes after exposure to ADHD medication during pregnancy: A systematic review and meta-analysis.
    Jiang HY; Zhang X; Jiang CM; Fu HB
    Pharmacoepidemiol Drug Saf; 2019 Mar; 28(3):288-295. PubMed ID: 30585374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between sleep duration and attention-deficit hyperactivity disorder: A systematic review and meta-analysis of observational studies
    Lee SH; Kim HB; Lee KW
    J Affect Disord; 2019 Sep; 256():62-69. PubMed ID: 31158717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study.
    Chen Q; Sjölander A; Runeson B; D'Onofrio BM; Lichtenstein P; Larsson H
    BMJ; 2014 Jun; 348():g3769. PubMed ID: 24942388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Completed suicide, ideation and attempt in attention deficit hyperactivity disorder.
    Impey M; Heun R
    Acta Psychiatr Scand; 2012 Feb; 125(2):93-102. PubMed ID: 22118301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention-deficit hyperactivity disorder and suicidality: The mediating effects of psychiatric comorbidities and family function.
    Chen YY; Chen YL; Gau SS
    J Affect Disord; 2019 Jan; 242():96-104. PubMed ID: 30173064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Risk of Suicide Attempts With Methylphenidate Treatment.
    Man KKC; Coghill D; Chan EW; Lau WCY; Hollis C; Liddle E; Banaschewski T; McCarthy S; Neubert A; Sayal K; Ip P; Schuemie MJ; Sturkenboom MCJM; Sonuga-Barke E; Buitelaar J; Carucci S; Zuddas A; Kovshoff H; Garas P; Nagy P; Inglis SK; Konrad K; Häge A; Rosenthal E; Wong ICK
    JAMA Psychiatry; 2017 Oct; 74(10):1048-1055. PubMed ID: 28746699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
    Castells X; Blanco-Silvente L; Cunill R
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Cerrillo-Urbina AJ; García-Hermoso A; Pardo-Guijarro MJ; Sánchez-López M; Santos-Gómez JL; Martínez-Vizcaíno V
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):494-507. PubMed ID: 29897263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Perry BA; Archer KR; Song Y; Ma Y; Green JK; Elefteriou F; Dahir KM
    Osteoporos Int; 2016 Jul; 27(7):2223-2227. PubMed ID: 26928186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.